Stroke. Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
Conditions
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
36 Years to 75 Years
Inclusion criteria
Inclusion criteria: Stroke due to involvement in the middle cerebral artery that the neurologist has diagnosed; The middle-aged and elderly people who are 36 to 75 years old; Patients who have cerebrovascular disease only once; People who have no history of stroke more than once; Time elapsed since the onset of the disease is at least six months after the stroke; Patients who do not have any complications of the nervous system such as Parkinson, Alzheimer, severe brain trauma, Hysteria, Epilepsy, history of brain surgery, brain tumor,any lesions and anomalies in the central nervous system; Patients who do not have orthopedic diseases and motor disorders (especially in the upper limb of affected side); Patients who do not have confusion, dizziness and tinnitus; Patients who do not have any psychological disorder; Patients who do not have the history of using psychotropic drugs; Patients who do not have visual impairment, hearing loss, speech disorder and secondary sensory problems caused by diabetes; Patients who do not have skin problems such as rubbing, skin scratches on the target area of the head.
Exclusion criteria
Exclusion criteria: Patients who their score in the upper limb function test are less than 65; Patients who their score in the memory impairment test are less than 23; Patients who have severe stroke severity; The participants who leave test for any reason; Severe fatigue.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reaction time. Timepoint: Before intervention, Immediately and 24 hours after intervention. Method of measurement: In millisecond and using Superlab 5 software.;Error. Timepoint: Before intervention, Immediately and 24 hours after intervention. Method of measurement: Based on the percentage and using Superlab 5 software.;Motor skill. Timepoint: Before intervention, Immediately and 24 hours after intervention. Method of measurement: Based on the calculation of the reaction time and error, using Superlab 5 software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAilin Talimkhani
Hamedan University of Medical Sciences
Outcome results
None listed